VFEND Side Effects

7022614-5 | Hypotension, Muscular Weakness
on Sep 20, 2010 Male patient from ITALY , 52 years of age, was diagnosed with pneumonia fungal and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, muscular weakness. Vfend dosage: 1200 Mg, Daily. During the same period patient was treated with ACICLOVIR (View Aciclovir Review and Aciclovir Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ZYVOX (View Zyvox Review and Zyvox Label ), SELEPARINA (View Seleparina Review and Seleparina Label ), CORDARONE X ^SANOFI^ (View Cordarone X ^sanofi^ Review and Cordarone X ^sanofi^ Label ), EUTIROX (View Eutirox Review and Eutirox Label ). Patient was hospitalized.

7022473-0 | Acute Myeloid Leukaemia, Pancytopenia
Patient was taking Vfend (View Usage). Patient had the following side effects: acute myeloid leukaemia, pancytopenia on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 224.9 lb, was diagnosed with bronchopulmonary aspergillosis, myeloid leukaemia and. Vfend dosage: 200 Mg, 2x/day.

7021319-4 | Abdominal Discomfort, Liver Disorder
Adverse event was reported on Sep 17, 2010 by a Male patient taking Vfend (View Usage) (Dosage: Unk) was diagnosed with osteomyelitis fungal and. Location: UNITED STATES , 47 years of age, After Vfend was administered, patient had the following side effects: abdominal discomfort, liver disorder.

7020797-4 | Agitation, Confusional State, Hallucination, Visual, Rash
on Sep 15, 2010 Male patient from FRANCE , 69 years of age, was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, confusional state, hallucination, visual, rash (What is rash?). Vfend dosage: .


7016978-6 | Condition Aggravated
on Sep 15, 2010 Male patient from FRANCE , 70 years of age, was treated with Vfend (View Usage). Patient had the following side effects: condition aggravated. Vfend dosage: . During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), AMIKIN (500 Mg, Unk) (View Amikin Review and Amikin Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), OFLOCET (View Oflocet Review and Oflocet Label ).

7016976-2 | Hepatitis
Patient was taking Vfend (View Usage). After Vfend was administered, patient had the following side effects: hepatitis (What is hepatitis?) on Sep 15, 2010 from FRANCE Additional patient health information: Male patient , 57 years of age, . Vfend dosage: . During the same period patient was treated with ZYVOX (View Zyvox Review and Zyvox Label ), CASPOFUNGIN ^MSD^ (View Caspofungin ^msd^ Review and Caspofungin ^msd^ Label ).

7016969-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bone Marrow Failure
Adverse event was reported on Sep 15, 2010 by a Female patient taking Vfend (View Usage) (Dosage: ) . Location: FRANCE , child 2 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

7016960-9 | Arthralgia, Muscle Spasms, Muscular Weakness
on Sep 15, 2010 Male patient from FRANCE , 60 years of age, was treated with Vfend (View Usage). Patient had the following side effects: arthralgia, muscle spasms, muscular weakness. Vfend dosage: .

7016922-1 | Cardiac Arrest, Respiratory Arrest
on Sep 15, 2010 Female patient from FRANCE , 19 years of age, was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. Vfend dosage: . During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ACUPAN (View Acupan Review and Acupan Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MOPRAL (View Mopral Review and Mopral Label ).

7016315-7 | Altered State Of Consciousness, Hepatic Function Abnormal, Renal Salt-wasting Syndrome
Patient was taking Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, hepatic function abnormal, renal salt-wasting syndrome on Sep 15, 2010 from JAPAN Additional patient health information: Male patient , 74 years of age, weighting 114.4 lb, was diagnosed with systemic mycosis and. Vfend dosage: 200 Mg, 2x/day. During the same period patient was treated with ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), MICARDIS (Unk) (View Micardis Review and Micardis Label ), ALTAT (View Altat Review and Altat Label ), PREDONINE (View Predonine Review and Predonine Label ), BIO THREE (Unk) (View Bio Three Review and Bio Three Label ), FUNGIZONE (Unk) (View Fungizone Review and Fungizone Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ), ACTONEL (Unk) (View Actonel Review and Actonel Label ). Patient was hospitalized.

7013451-6 | Aspergillosis
Adverse event was reported on Sep 14, 2010 by a Female patient taking Vfend (View Usage) (Dosage: Unk) was diagnosed with prophylaxis and. Location: UNITED STATES , child 9 years of age, Patient had the following side effects: aspergillosis.

7007394-1 | Cholestasis, Hepatocellular Injury
on Sep 07, 2010 Female patient from FRANCE , 54 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: cholestasis, hepatocellular injury. Vfend dosage: 250 Mg, 2x/day. During the same period patient was treated with BUMEX (2 Ml Per Hour) (View Bumex Review and Bumex Label ), ACTRAPID (Unk) (View Actrapid Review and Actrapid Label ), FORLAX (View Forlax Review and Forlax Label ), LOXEN (10 Ml Per Hour) (View Loxen Review and Loxen Label ).

7006144-2 | Gait Disturbance, Muscle Spasms
on Sep 14, 2010 Male patient from UNITED STATES , weighting 138.9 lb, was diagnosed with lung infection and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: gait disturbance, muscle spasms. Vfend dosage: Unk Mg, 2x/day.

6992094-4 | Dizziness, Feeling Abnormal, Gaze Palsy, Hepatic Function Abnormal, Hiccups
Patient was taking Vfend (View Usage). Patient had the following side effects: dizziness (What is dizziness?), feeling abnormal, gaze palsy, hepatic function abnormal, hiccups on Sep 06, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 90.39 lb, was diagnosed with bronchopulmonary aspergillosis and. Vfend dosage: 300 Mg, 2x/day. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), MEROPEN (Unk) (View Meropen Review and Meropen Label ), AMPHOTERICIN B (1.5 Mg, Unk) (View Amphotericin B Review and Amphotericin B Label ), CIPROFLOXACIN HCL (Unk) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), VANCOMYCIN HYDROCHLORIDE (Unk) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6992004-X | Hypotension, Hypotonia
Adverse event was reported on Sep 13, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 800 Mg Daily) was diagnosed with pneumonia fungal and. Location: ITALY , 52 years of age, After Vfend was administered, patient had the following side effects: hypotension, hypotonia. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ACICLOVIR (View Aciclovir Review and Aciclovir Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), SELEPARINA (View Seleparina Review and Seleparina Label ), EUTIROX (View Eutirox Review and Eutirox Label ). Patient was hospitalized.

6991870-1 | Cholestasis, Hepatocellular Injury
on Sep 07, 2010 Female patient from FRANCE , 54 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatocellular injury. Vfend dosage: 250 Mg, 2x/day. During the same period patient was treated with BUMEX (2 Ml Per Hour) (View Bumex Review and Bumex Label ), ACTRAPID (Unk) (View Actrapid Review and Actrapid Label ), FORLAX (View Forlax Review and Forlax Label ), LOXEN (10 Ml Per Hour) (View Loxen Review and Loxen Label ).

6988674-2 | Ataxia, Feeling Abnormal, Feeling Drunk
on Jul 17, 2009 Male patient from UNITED STATES , 48 years of age, weighting 179.9 lb, was diagnosed with aspergillosis and was treated with Vfend (View Usage). Patient had the following side effects: ataxia (What is ataxia?), feeling abnormal, feeling drunk. Vfend dosage: 200 Mg, 2x/day. During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MULTIVITAMINS (ASCORBIC ACID, ERGOCALCIFEROL, FOLIC ACID, NICOTINAMIDE (View Multivitamins (ascorbic Acid, Ergocalciferol, Folic Acid, Nicotinamide Review and Multivitamins (ascorbic Acid, Ergocalciferol, Folic Acid, Nicotinamide Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ).

6988671-7 | Skin Exfoliation
Patient was taking Vfend (View Usage). After Vfend was administered, patient had the following side effects: skin exfoliation on Jun 03, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 149.9 lb, was diagnosed with sinusitis fungal and. Vfend dosage: 200 Mg, 2x/day, Oral. During the same period patient was treated with ALEVE (View Aleve Review and Aleve Label ), SUDAFED 12 HOUR (View Sudafed 12 Hour Review and Sudafed 12 Hour Label ), EXCEDRIN EXTRA STRENGTH (ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL) (View Excedrin Extra Strength (acetylsalicylic Acid, Caffeine, Paracetamol) Review and Excedrin Extra Strength (acetylsalicylic Acid, Caffeine, Paracetamol) Label ).

6988664-X | Hallucination
Adverse event was reported on Jun 01, 2010 by a Male patient taking Vfend (View Usage) (Dosage: ) . Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: hallucination.

6988639-0 | Abdominal Pain, Confusional State, Hallucination, Hepatic Enzyme Increased
on Aug 25, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with pneumonia fungal and was treated with Vfend (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), confusional state, hallucination, hepatic enzyme increased. Vfend dosage: 600 Mg, 1x/day. Patient was hospitalized.

6988534-7 | Photophobia, Somnolence, Speech Disorder
on Sep 09, 2010 Female patient from JAPAN , 66 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: photophobia, somnolence, speech disorder. Vfend dosage: 200 Mg/day. During the same period patient was treated with TAKEPRON (View Takepron Review and Takepron Label ), DEPROMEL (View Depromel Review and Depromel Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), PREDONINE (View Predonine Review and Predonine Label ).

6988458-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Nausea
Patient was taking Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, nausea (What is nausea?) on Mar 08, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with antifungal prophylaxis and. Vfend dosage: 200 Mg, 2x/day.

6988444-5 | Hepatic Failure
Adverse event was reported on Dec 02, 2009 by a Female patient taking Vfend (View Usage) (Dosage: ) was diagnosed with aspergillosis and. Location: UNITED STATES , 50 years of age, Patient had the following side effects: hepatic failure.

6985534-8 | Dizziness, Feeling Abnormal, Gaze Palsy, Hepatic Function Abnormal, Hiccups
on Sep 06, 2010 Male patient from JAPAN , 66 years of age, weighting 90.39 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: dizziness (What is dizziness?), feeling abnormal, gaze palsy, hepatic function abnormal, hiccups. Vfend dosage: 300 Mg, 2x/day. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), MEROPEN (Unk) (View Meropen Review and Meropen Label ), AMPHOTERICIN B (1.5 Mg, Unk) (View Amphotericin B Review and Amphotericin B Label ), CIPROFLOXACIN HCL (Unk) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), VANCOMYCIN HYDROCHLORIDE (Unk) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6984852-7 | Arthralgia, Eye Disorder, Hypoaesthesia Facial, Pain In Extremity, Photosensitivity Reaction
on Sep 07, 2010 Male patient from JAPAN , 59 years of age, was diagnosed with encephalitis (What is encephalitis?) and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, eye disorder, hypoaesthesia facial, pain in extremity, photosensitivity reaction. Vfend dosage: 200mg Daily. During the same period patient was treated with AMBISOME (Unk) (View Ambisome Review and Ambisome Label ), MYCOSYST (400mg Daily) (View Mycosyst Review and Mycosyst Label ), FLUCYTOSINE (View Flucytosine Review and Flucytosine Label ).

6981280-5 | Abnormal Behaviour, Agitation, Anxiety, Suicidal Ideation
Patient was taking Vfend (View Usage). Patient had the following side effects: abnormal behaviour, agitation, anxiety (What is anxiety?), suicidal ideation on Jul 21, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 180.8 lb, was diagnosed with osteomyelitis and. Vfend dosage: 320 Mg, 2x/day, Intravenous. During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), PAXIL (View Paxil Review and Paxil Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), NASONEX (View Nasonex Review and Nasonex Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ).

6981277-5 | Tachycardia
Adverse event was reported on Sep 03, 2009 by a Male patient taking Vfend (View Usage) (Dosage: 200 Mg, 2x/day, Intravenous) was diagnosed with aspergillosis and. Location: UNITED STATES , weighting 130.1 lb, After Vfend was administered, patient had the following side effects: tachycardia. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), POTASSIUM (POTASSIUM) (View Potassium (potassium) Review and Potassium (potassium) Label ), MICAFUNGIN SODIUM (MICAFUNGIN SODIUM) (View Micafungin Sodium (micafungin Sodium) Review and Micafungin Sodium (micafungin Sodium) Label ), MEGACE (View Megace Review and Megace Label ), LASIX (View Lasix Review and Lasix Label ), FLOVENT (View Flovent Review and Flovent Label ).

6977967-0 | Hypotension, Muscular Weakness
on Sep 06, 2010 Male patient from ITALY , 52 years of age, was diagnosed with pneumonia fungal and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, muscular weakness. Vfend dosage: 1200 Mg, Daily. During the same period patient was treated with ACICLOVIR (View Aciclovir Review and Aciclovir Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ZYVOX (View Zyvox Review and Zyvox Label ), SELEPARINA (View Seleparina Review and Seleparina Label ), CORDARONE X ^SANOFI^ (View Cordarone X ^sanofi^ Review and Cordarone X ^sanofi^ Label ), EUTIROX (View Eutirox Review and Eutirox Label ). Patient was hospitalized.

6976510-X | Hallucination
on Aug 31, 2010 Female patient from UNITED STATES , 14 years of age, was treated with Vfend (View Usage). Patient had the following side effects: hallucination. Vfend dosage: Unk.

6976100-9 | Inappropriate Antidiuretic Hormone Secretion, Liver Disorder
Patient was taking Vfend (View Usage). After Vfend was administered, patient had the following side effects: inappropriate antidiuretic hormone secretion, liver disorder on Aug 31, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with bronchopulmonary aspergillosis, hyperuricaemia, gastric ulcer and. Vfend dosage: 200 Mg, 2x/day. During the same period patient was treated with URINORM (50 Mg, 1x/day) (View Urinorm Review and Urinorm Label ), TAKEPRON (15 Mg, 1x/day) (View Takepron Review and Takepron Label ). Patient was hospitalized.

6976099-5 | Eye Disorder, Hypoaesthesia Oral
Adverse event was reported on Aug 30, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 200 Mg, 2x/day) was diagnosed with meningitis cryptococcal and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: eye disorder, hypoaesthesia oral.

6969225-5 | Actinic Keratosis, Squamous Cell Carcinoma
on Aug 26, 2010 Male patient from JAPAN , 79 years of age, was diagnosed with bronchopulmonary aspergillosis, cough and was treated with Vfend (View Usage). Patient had the following side effects: actinic keratosis, squamous cell carcinoma. Vfend dosage: 100 Mg, 2x/day. During the same period patient was treated with HUSTAZOL (10 Mg, 3x/day) (View Hustazol Review and Hustazol Label ).

6968926-2 | Diarrhoea, Malaise, Nausea
on Aug 27, 2010 Male patient from UNITED STATES , weighting 175.0 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: diarrhoea, malaise, nausea (What is nausea?). Vfend dosage: 200 Mg, 2x/day. During the same period patient was treated with LYRICA (Unk) (View Lyrica Review and Lyrica Label ), LEXAPRO (Unk) (View Lexapro Review and Lexapro Label ).

6967649-3 | Photophobia, Vision Blurred
Patient was taking Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: photophobia, vision blurred on Aug 26, 2010 from GREECE Additional patient health information: Female patient , 71 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Vfend dosage: 400 Mg, Every 12h.

6967590-6 | Hypotension, Hypotonia
Adverse event was reported on Aug 27, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 800 Mg Daily) was diagnosed with pneumonia fungal and. Location: ITALY , 52 years of age, Patient had the following side effects: hypotension, hypotonia. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ACICLOVIR (View Aciclovir Review and Aciclovir Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CORDARONE (View Cordarone Review and Cordarone Label ), SELEPARINA (View Seleparina Review and Seleparina Label ), EUTIROX (View Eutirox Review and Eutirox Label ). Patient was hospitalized.

6967585-2 | Coagulopathy, Condition Aggravated, Hypoglycaemia
on Aug 26, 2010 Male patient from SPAIN , 40 years of age, was diagnosed with fungal infection (What is fungal infection?), respiratory tract infection and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: coagulopathy, condition aggravated, hypoglycaemia. Vfend dosage: 440 Mg, 2x/day. During the same period patient was treated with TYGACIL (50 Mg, 2x/day) (View Tygacil Review and Tygacil Label ), SANDIMMUNE (From 125 To 220 Mg, 2x/day) (View Sandimmune Review and Sandimmune Label ), PANTOPRAZOLE SODIUM (Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CLEXANE (40 Mg) (View Clexane Review and Clexane Label ).

6967584-0 | Angina Pectoris, Unresponsive To Stimuli
on Aug 25, 2010 Female patient from CHINA , 77 years of age, was diagnosed with aspergillosis and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, unresponsive to stimuli. Vfend dosage: 6 Mg/kg, 2x/day.

6962474-1 | Eye Disorder
Patient was taking Vfend (View Usage). Patient had the following side effects: eye disorder on Aug 23, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, . Vfend dosage: 200 Mg, 2x/day.

6960733-X | Coordination Abnormal, Gait Disturbance, Tremor
Adverse event was reported on Aug 20, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with gastrointestinal fungal infection and. Location: SPAIN , 74 years of age, After Vfend was administered, patient had the following side effects: coordination abnormal, gait disturbance, tremor.

6941830-1 | Blister, Burning Sensation, Hypersensitivity
on Aug 17, 2010 Male patient from UNITED STATES , weighting 140.0 lb, was diagnosed with aspergillosis and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: blister, burning sensation, hypersensitivity. Vfend dosage: 400 Mg, Daily. During the same period patient was treated with PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ).

6939991-3 | Completed Suicide
on Aug 13, 2010 Male patient from UNITED STATES , weighting 194.0 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Vfend (View Usage). Patient had the following side effects: completed suicide. Vfend dosage: 200 Mg, 2x/day.

6938840-7 | Blister, Rash
Patient was taking Vfend (View Usage). After Vfend was administered, patient had the following side effects: blister, rash (What is rash?) on Aug 17, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 130.1 lb, was diagnosed with ear disorder and. Vfend dosage: 300 Mg, 2x/day.

6938359-3 | Altered State Of Consciousness
Adverse event was reported on Aug 12, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 4 Mg/kg) . Location: JAPAN , 45 years of age, Patient experienced the following unwanted or unexpected effects: altered state of consciousness.

6936178-5 | Gait Disturbance, Muscle Spasms
on Aug 11, 2010 Male patient from UNITED STATES , weighting 138.0 lb, was diagnosed with lung infection and was treated with Vfend (View Usage). Patient had the following side effects: gait disturbance, muscle spasms. Vfend dosage: Unk Mg, 2x/day.

6933253-6 | Dizziness, Feeling Abnormal, Gaze Palsy, Hepatic Function Abnormal, Hiccups
on Aug 09, 2010 Male patient from JAPAN , 66 years of age, weighting 90.39 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: dizziness (What is dizziness?), feeling abnormal, gaze palsy, hepatic function abnormal, hiccups. Vfend dosage: 300 Mg, 2x/day. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), MEROPEN (Unk) (View Meropen Review and Meropen Label ), AMPHOTERICIN B (1.5 Mg, Unk) (View Amphotericin B Review and Amphotericin B Label ), CIPROFLOXACIN HCL (Unk) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), VANCOMYCIN HYDROCHLORIDE (Unk) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

6930335-X | Bronchopulmonary Aspergillosis, Dizziness, Eye Rolling, Feeling Abnormal, Hiccups, Liver Disorder
Patient was taking Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, dizziness (What is dizziness?), eye rolling, feeling abnormal, hiccups, liver disorder on Jul 07, 2010 from JAPAN Additional patient health information: Male patient , 66 years of age, was diagnosed with dementia (What is dementia?) and. Vfend dosage: 300 Mg, 2x/day. During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), LENDORMIN (Unk) (View Lendormin Review and Lendormin Label ), MICARDIS (View Micardis Review and Micardis Label ), FLUITRAN (View Fluitran Review and Fluitran Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FLAVERIC (View Flaveric Review and Flaveric Label ). Patient was hospitalized.

6927869-0 | Alopecia, Asthenopia, Eye Discharge, Eye Infection
Adverse event was reported on Aug 05, 2010 by a Male patient taking Vfend (View Usage) (Dosage: 50 Mg, 2x/day) was diagnosed with aspergillosis and. Location: FINLAND , 75 years of age, Patient had the following side effects: alopecia, asthenopia, eye discharge, eye infection (What is eye infection?).

6920936-7 | Human Herpesvirus 6 Infection
on Aug 02, 2010 Male patient from JAPAN , child 12 years of age, was treated with Vfend (View Usage). After Vfend was administered, patient had the following side effects: human herpesvirus 6 infection. Vfend dosage: .

6916262-2 | Mass, Photosensitivity Reaction
on Jul 29, 2010 Male patient from UNITED STATES , weighting 229.3 lb, was diagnosed with coccidioidomycosis, diabetes mellitus and was treated with Vfend (View Usage). Patient experienced the following unwanted or unexpected effects: mass, photosensitivity reaction. Vfend dosage: Unk. During the same period patient was treated with ACTOS (20 Mg, 2x/day) (View Actos Review and Actos Label ), METFORMIN (1000 Mg, 2x/day) (View Metformin Review and Metformin Label ), GLIPIZIDE (2 Mg, 2x/day) (View Glipizide Review and Glipizide Label ). Patient was hospitalized.

6914154-6 | Blood Creatine Phosphokinase Increased, Convulsion, Inappropriate Antidiuretic Hormone Secretion, Photophobia
Patient was taking Vfend (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, convulsion, inappropriate antidiuretic hormone secretion, photophobia on Jul 28, 2010 from JAPAN Additional patient health information: Male patient , child 11 years of age, weighting 70.55 lb, was diagnosed with pyrexia, bone marrow conditioning regimen and. Vfend dosage: 250 Mg, 2x/day. During the same period patient was treated with ALKERAN (72 Mg, 1x/day) (View Alkeran Review and Alkeran Label ).